The University of Chicago Header Logo

Connection

Tao Pan to Cell Line, Tumor

This is a "connection" page, showing publications Tao Pan has written about Cell Line, Tumor.
Connection Strength

0.869
  1. Discovery of 2,4-pyrimidinediamine derivatives as potent dual inhibitors of ALK and HDAC. Eur J Med Chem. 2021 Nov 15; 224:113672.
    View in: PubMed
    Score: 0.113
  2. Detection and quantification of glycosylated queuosine modified tRNAs by acid denaturing and APB gels. RNA. 2020 09; 26(9):1291-1298.
    View in: PubMed
    Score: 0.104
  3. Sensitive and quantitative probing of pseudouridine modification in mRNA and long noncoding RNA. RNA. 2019 09; 25(9):1218-1225.
    View in: PubMed
    Score: 0.098
  4. Overexpression of initiator methionine tRNA leads to global reprogramming of tRNA expression and increased proliferation in human epithelial cells. RNA. 2013 Apr; 19(4):461-6.
    View in: PubMed
    Score: 0.063
  5. Anti-tumor effects of an engineered "killer" transfer RNA. Biochem Biophys Res Commun. 2012 Oct 12; 427(1):148-53.
    View in: PubMed
    Score: 0.061
  6. tRNA over-expression in breast cancer and functional consequences. Nucleic Acids Res. 2009 Nov; 37(21):7268-80.
    View in: PubMed
    Score: 0.050
  7. High levels of tRNA abundance and alteration of tRNA charging by bortezomib in multiple myeloma. Biochem Biophys Res Commun. 2009 Jul 24; 385(2):160-4.
    View in: PubMed
    Score: 0.049
  8. EZH2 inhibitor SHR2554 enhances the anti-tumor efficacy of HDAC inhibitor Chidamide through STAT1 in T-cell lymphoma. Cell Death Dis. 2025 Jul 14; 16(1):522.
    View in: PubMed
    Score: 0.037
  9. Loss of DRD5P2 in hypoxia attenuates Rock2 degradation to promote EMT and gastric cancer metastasis. Biochim Biophys Acta Mol Basis Dis. 2025 Aug; 1871(6):167858.
    View in: PubMed
    Score: 0.037
  10. Aptamer-drug conjugates-loaded bacteria for pancreatic cancer synergistic therapy. Signal Transduct Target Ther. 2024 10 14; 9(1):272.
    View in: PubMed
    Score: 0.035
  11. A Glutathione-Consuming Bimetallic Nano-Bomb with the Combination of Photothermal and Chemodynamic Therapy for Tumors: An in vivo and in vitro Study. Int J Nanomedicine. 2024; 19:8541-8553.
    View in: PubMed
    Score: 0.035
  12. BPTF Drives Gastric Cancer Resistance to EGFR Inhibitor by Epigenetically Regulating the C-MYC/PLCG1/Perk Axis. Adv Sci (Weinh). 2023 12; 10(34):e2303091.
    View in: PubMed
    Score: 0.033
  13. Long noncoding RNA LINC01132 enhances immunosuppression and therapy resistance via NRF1/DPP4 axis in hepatocellular carcinoma. J Exp Clin Cancer Res. 2022 Sep 08; 41(1):270.
    View in: PubMed
    Score: 0.031
  14. DNA N6-methyladenine involvement and regulation of hepatocellular carcinoma development. Genomics. 2022 03; 114(2):110265.
    View in: PubMed
    Score: 0.029
  15. Identification of ARGLU1 as a potential therapeutic target for gastric cancer based on genome-wide functional screening data. EBioMedicine. 2021 Jul; 69:103436.
    View in: PubMed
    Score: 0.028
  16. Inhibition of DNA-PK by gefitinib causes synergism between gefitinib and cisplatin in NSCLC. Int J Oncol. 2020 10; 57(4):939-955.
    View in: PubMed
    Score: 0.026
  17. Interaction of tRNA with MEK2 in pancreatic cancer cells. Sci Rep. 2016 06 15; 6:28260.
    View in: PubMed
    Score: 0.020
  18. The dynamic N(1)-methyladenosine methylome in eukaryotic messenger RNA. Nature. 2016 Feb 25; 530(7591):441-6.
    View in: PubMed
    Score: 0.019
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.